Literature DB >> 6409931

Gluten-sensitive enteropathy. Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to wheat gliadin.

J B Weiss, R K Austin, M S Schanfield, M F Kagnoff.   

Abstract

Anti-gliadin antibody was measured by radioimmunoassay in 30 Caucasians with gluten-sensitive enteropathy (GSE). 22 GSE patients maintained on a gluten-free diet for 1.5 to 20 yr (mean duration 76 mo) had elevated serum concentrations of IgG antigliadin antibody. Among GSE patients on a gluten-free diet, antigliadin antibody was seen only in those having the chromosome 14-encoded IgG immunoglobulin heavy chain allotype marker G2m(n). IgG antigliadin antibody was found in GSE patients with G2m(n) regardless of whether the HLA-B8 and/or -DR3 major histocompatibility complex antigens that occur frequently in GSE were present. No patient lacking G2m(n) had significant levels of antigliadin antibody. The association between antigliadin antibody and the immunoglobulin heavy chain allotype marker G2m(n) in GSE patients likely reflects the presence of Gmn-linked variable region genes or Gmn-linked genes that regulate variable region gene expression.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409931      PMCID: PMC1129164          DOI: 10.1172/jci110988

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  SIGNIFICANCE OF ANTIBODIES TO DIETARY PROTEINS IN THE SERUMS OF PATIENTS WITH NONTROPICAL SPRUE.

Authors:  R M KIVEL; D H KEARNS; D LIEBOWITZ
Journal:  N Engl J Med       Date:  1964-10-08       Impact factor: 91.245

2.  SEROLOGIC REACTIONS TO GLUTEN AND COW'S MILK PROTEINS IN GASTROINTESTINAL DISEASE.

Authors:  K B TAYLOR; S C TRUELOVE; R WRIGHT
Journal:  Gastroenterology       Date:  1964-02       Impact factor: 22.682

3.  Genetic basis of gluten-sentitive enteropathy.

Authors:  A S Peña; D L Mann; N E Hague; J A Heck; H A van Leeuwen; J J van Rood; W Strober
Journal:  Gastroenterology       Date:  1978-08       Impact factor: 22.682

4.  Immunofluorescent serum gliadin antibodies in children with coeliac disease and various malabsorptive disorders. II. Specificity of Gliadin antibodies: immunoglobulin classes, immunogenic properties of wheat protein fractions, and pathogenic significance of food antibodies in coeliac disease.

Authors:  M Stern; K Fischer; R Grüttner
Journal:  Eur J Pediatr       Date:  1979-03-01       Impact factor: 3.183

5.  Antibodies to gluten and reticulin in gastrointestinal diseases.

Authors:  K P Eterman; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

6.  Specific B-cell antigens associated with gluten-sensitive enteropathy and dermatitis herpetiformis.

Authors:  D L Mann; S I Katz; D L Nelson; L D Abelson
Journal:  Lancet       Date:  1976-01-17       Impact factor: 79.321

7.  Jejunal mucosal immunoglobulin-containing cells and jejunal fluid immunoglobulins in adult coeliac disease and dermatitis herpetiformis.

Authors:  M Lancaster-Smith; P Kumar; R Marks; M L Clark; A M Dawson
Journal:  Gut       Date:  1974-05       Impact factor: 23.059

8.  Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.

Authors:  T J Lawley; R P Hall; A S Fauci; S I Katz; M I Hamburger; M M Frank
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

9.  Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.

Authors:  A Ferguson; T T MacDonald; J P McClure; R J Holden
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

10.  Some characteristics of immunofluorescence tests for antibodies against gluten, using wheat grain sections or gliadin coated sepharose beads.

Authors:  J Jonsson; W Schilling
Journal:  Acta Pathol Microbiol Scand C       Date:  1981-08
View more
  19 in total

Review 1.  The immunology of coeliac disease.

Authors:  G J Mantzaris; W M Rosenberg; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  Gm allotype system and autoimmune diseases.

Authors:  M Abu-Shakra; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Immunoglobulin G genotypes and the risk of schizophrenia.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Robert C Elston
Journal:  Hum Genet       Date:  2016-07-08       Impact factor: 4.132

4.  Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease.

Authors:  M F Kagnoff; Y J Paterson; P J Kumar; D D Kasarda; F R Carbone; D J Unsworth; R K Austin
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

5.  Molecular analysis of HLA-DQ A alleles in coeliac disease lack of a unique disease-associated sequence.

Authors:  V Mantovani; G R Corazza; G Angelini; L Delfino; M Frisoni; P Mirri; R A Valentini; P Barboni; G Gasbarrini; G B Ferrara
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

6.  Gm typing of Irish coeliac patients and controls does not help locate the "second" coeliac gene.

Authors:  M Hannigan; M Bourke; F M Stevens; C F McCarthy
Journal:  Ir J Med Sci       Date:  1991-02       Impact factor: 1.568

7.  Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane proteins of Moraxella catarrhalis.

Authors:  R T Carson; D F McDonald; M A Kehoe; J E Calvert
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

Review 8.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

9.  T-cell and plasma cell populations in coeliac small intestinal mucosa in relation to dermatitis herpetiformis.

Authors:  D Jenkins; A Goodall; B Scott
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

10.  Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease.

Authors:  S Husby; N Foged; V A Oxelius; S E Svehag
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.